Ivermectin, HCQs dropped from Health Ministry's latest COVID-19 Guidelines Lalhmangaihkimi3 Jan 2022 9:00 AM ISTNew Delhi: In the light of the recent rising COVID-19 cases, the Union Ministry of Health and Family welfare has released the updated guidelines for...
Belgium to buy courses of Pfizer, Merck COVID pills Ruchika Sharma3 Jan 2022 9:00 AM ISTBrussels: Belgium has agreed to buy 10,000 courses each of the COVID-19 antiviral oral treatments developed by Pfizer and Merck & CO, a...
Pfizer-BioNTech COVID vaccine causes mostly mild side effects in children aged 5 to 11 years, says USCDC Ruchika Sharma2 Jan 2022 10:00 AM ISTNew Delhi: Pfizer Inc and BioNTech SE's COVID-19 vaccine caused mostly mild side effects in children aged 5 to 11 years, according to data...
Manipal Hospital warned for overcharging COVID patients, told to refund excess amount Revu suresh2 Jan 2022 10:00 AM ISTBengaluru: Manipal hospital has been directed by the Karnataka health department to return the excess amount of money collected from three COVID...
Pfizer COVID drug Paxlovid gets approval in Britain Ruchika Sharma2 Jan 2022 9:30 AM ISTPaxlovid is made of two active substances which come as two separate pills taken twice a day together for five days.
13 pharma majors to launch anti-COVID drug Molnupiravir Medical Dialogues Team1 Jan 2022 7:36 PM ISTNew Delhi: Thirteen Indian pharmaceutical companies, including Torrent, Cipla, Sun Pharma, Dr Reddy's, Natco, Mylan, Hetero, Optimus will be...
Doctor certificate not required for 60 years plus to avail boosters: Centre Roshni Dhar1 Jan 2022 5:50 PM ISTThe Union Government has said that people above 60 years with comorbidities will not be required to upload or provide a medical certificate from a...
COVID 19 drug Paxlovid Dr. Nandita Mohan1 Jan 2022 4:38 PM ISTAs the number of Omicron cases continues to increase in India and worldwide, recently approved antiviral pills could be a game-changer for the most ...
Serum Institute files for full CDSCO approval of Covishield Ruchika Sharma1 Jan 2022 1:01 PM ISTNew Delhi: Serum Institute of India (SII) CEO Adar Poonawala on Friday said the vaccines major has applied to Indian authorities for full market...
Novavax files data with USFDA to back COVID vaccine Ruchika Sharma1 Jan 2022 10:00 AM ISTGaithersburg: Novavax, Inc. has announced that the company has completed submission of the final data package, including the complete chemistry,...
Cipla plans to launch Molnupiravir under brand name Cipmolnu Roshni Dhar31 Dec 2021 5:01 PM ISTCipla Limited announced that the company has been granted permission by the Drug Controller General of India (DCGI) for the launch of Molnupiravir in...
Health Bulletin 31/December/2021 Roshni Dhar31 Dec 2021 5:00 PM ISTHere are Top Health stories of the dayFMGE December Result 2021 (OUT): NBE announces Foreign Medical Graduate Examination for December SessionThe...
